Janney Montgomery Scott’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-46,756
| Closed | -$3.96M | – | 2047 |
|
|
2018
Q4 | $3.96M | Sell |
46,756
-1,400
| -3% | -$119K | 0.04% | 422 |
|
|
2018
Q3 | $8.25M | Sell |
48,156
-601
| -1% | -$103K | 0.07% | 294 |
|
|
2018
Q2 | $6.3M | Buy |
48,757
+5,080
| +12% | +$657K | 0.06% | 324 |
|
|
2018
Q1 | $4.5M | Sell |
43,677
-657
| -1% | -$67.7K | 0.05% | 400 |
|
|
2017
Q4 | $3.79M | Sell |
44,334
-1,077
| -2% | -$92K | 0.04% | 438 |
|
|
2017
Q3 | $3.86M | Buy |
+45,411
| New | +$3.86M | 0.04% | 406 |
|
|
2017
Q2 | – | Sell |
-3,929
| Closed | -$259K | – | 1781 |
|
|
2017
Q1 | $259K | Sell |
3,929
-1,125
| -22% | -$74.2K | ﹤0.01% | 1481 |
|
|
2016
Q4 | $320K | Buy |
5,054
+1,407
| +39% | +$89.1K | ﹤0.01% | 1291 |
|
|
2016
Q3 | $232K | Buy |
+3,647
| New | +$232K | ﹤0.01% | 1319 |
|
|
2015
Q3 | – | Sell |
-3,429
| Closed | -$216K | – | 1429 |
|
|
2015
Q2 | $216K | Buy |
+3,429
| New | +$216K | ﹤0.01% | 1737 |
|